Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease

scientific article published on October 2008

Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MPG.0B013E31817E2BFB
P932PMC publication ID2628810
P698PubMed publication ID18852641
P5875ResearchGate publication ID23314738

P50authorPeter F. WhitingtonQ124426406
P2093author name stringCraig J McClain
Swati Joshi-Barve
Miriam B Vos
Shirish Barve
John D Carew
P2860cites workThe natural history of nonalcoholic fatty liver disease: a population-based cohort studyQ29617161
Long-term follow-up of patients with NAFLD and elevated liver enzymesQ29620024
Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.Q34302662
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.Q34327135
Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver diseaseQ35565097
Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimensQ35877265
Prevalence of fatty liver in children and adolescents.Q36610508
Fatty liver and the metabolic syndromeQ36724600
Worldwide trends in childhood overweight and obesity.Q36954471
Decreased prevalence of nonalcoholic fatty liver disease in black obese childrenQ40497144
Keratin 8/18 breakdown and reorganization during apoptosis.Q40546224
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalitiesQ43552270
The utility of radiological imaging in nonalcoholic fatty liver disease.Q44116674
Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescentsQ46352202
Histopathology of pediatric nonalcoholic fatty liver disease.Q46735998
Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver diseaseQ46852405
Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescentsQ46937251
Prevalence of abnormal serum aminotransferase values in overweight and obese adolescentsQ73854647
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver diseaseQ79788222
Diagnosis and treatment frequency for overweight children and adolescents at well child visitsQ81334884
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectliver diseaseQ929737
metabolic dysfunction–associated steatotic liver diseaseQ1546498
cell deathQ2383867
fatty liver diseaseQ6058862
P304page(s)481-485
P577publication date2008-10-01
P1433published inJournal of Pediatric Gastroenterology and NutritionQ6295721
P1476titleCytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease
P478volume47

Reverse relations

cites work (P2860)
Q37376332Advances in pediatric nonalcoholic fatty liver disease
Q42859204Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.
Q35676997Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
Q42610151Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease
Q27690667Current and emerging biomarkers of cell death in human disease.
Q35064093Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis
Q37599777Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
Q33844787Developmental origins of nonalcoholic fatty liver disease
Q53420247Differential expression of intermediate filaments in the process of developing hepatic steatosis.
Q38262890Keratin 18, Apoptosis, and Liver Disease in Children
Q37975158Nonalcoholic fatty liver disease in pediatric patients
Q37788538Nonalcoholic fatty liver disease: a challenge for pediatricians
Q36660316Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
Q50057357Pathogenesis of non-alcoholic fatty liver disease mediated by YAP.
Q52979087Pediatric Non-Alcoholic Fatty Liver Disease.
Q34636684Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
Q37976341Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.
Q35555722Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis
Q34440962Review article: the management of paediatric nonalcoholic fatty liver disease
Q28392515Serum cytokeratin 18 and cytokine elevations suggest a high prevalence of occupational liver disease in highly exposed elastomer/polymer workers
Q84914106Serum markers of hepatocyte apoptosis: current terminology and predictability in clinical practice
Q37863129The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful